Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LZM012 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of LZM012 for psoriasis is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LZM012

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Psoriasis | Phase 3 | Status: UNKNOWN